Form 8-K - Current report:
SEC Accession No. 0001274737-24-000091
Filing Date
2024-11-12
Accepted
2024-11-12 08:00:21
Documents
15
Period of Report
2024-11-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K exdx-20241112.htm   iXBRL 8-K 28679
2 EX-99.1 q32024exagenearningspressr.htm EX-99.1 134523
6 GRAPHIC image.jpg GRAPHIC 11705
  Complete submission text file 0001274737-24-000091.txt   319706

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT exdx-20241112.xsd EX-101.SCH 1779
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT exdx-20241112_lab.xml EX-101.LAB 22530
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT exdx-20241112_pre.xml EX-101.PRE 13041
17 EXTRACTED XBRL INSTANCE DOCUMENT exdx-20241112_htm.xml XML 2988
Mailing Address 1261 LIBERTY WAY VISTA CA 92081
Business Address 1261 LIBERTY WAY VISTA CA 92081 (760) 560-1501
EXAGEN INC. (Filer) CIK: 0001274737 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39049 | Film No.: 241443483
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)